Health ❯ Mental Health

Psychedelic Therapy

Psilocybin Ibogaine Research Clinical Trials MDMA PTSD Treatment Psychedelic Drugs Substance Use Clinical Research Treatment Options

Psilocybin Study Finds Brain Entropy Spike and Monthlong Imaging Changes

Experts urge larger trials to test whether trip intensity truly predicts lasting benefits.

White House Orders Fast-Track for Psychedelic Therapies and Limited Cannabis Rescheduling

FDA Clears First U.S. Trial of Ibogaine Derivative After Trump Order

FDA Fast-Tracks Reviews for Psilocybin and Methylone After Trump Order

Trump Orders Faster FDA Reviews of Psychedelics, Credits Joe Rogan for Push

Trump Order to Speed Psychedelic Therapies Sends Compass Pathways to 52-Week High

Trump Orders FDA To Fast-Track Psychedelic Reviews, Sets $50 Million For Ibogaine Research

Trump Signs Order to Fast-Track Psychedelic Treatments

Trump Signs Order to Speed Psychedelic Research for Veterans

Mega-Analysis Maps Common Brain Signature Across Psychedelics

Senate Weighs Casey Means for Surgeon General as Questions Mount Over Vaccines, Wellness Business, and Spiritualism

Michael Pollan’s ‘A World Appears’ Probes Consciousness, Questions AI Claims

Psilocybin Therapy Clears Second Phase 3 Test as Compass Pathways Preps FDA Bid

Single IV DMT Dose With Therapy Shows Rapid, Lasting Antidepressant Effect in Phase IIa Trial

Bryan Johnson Livestreams High-Dose Psilocybin Session as Tech Luminaries Tune In

Conor McGregor Says He Underwent Ibogaine Therapy in Tijuana, Reports Vivid Spiritual Visions

DMT Pushes Brain Away From Critical Balance, Study Finds

Australian Trial Finds Psilocybin Therapy Eases End-of-Life Depression and Anxiety

Psilocybin Extends Lifespan in Cells and Mice and Paves Way for Human Trials

Psilocybin Anti-Aging Efficacy in Cells and Mice Paves Path to Human Trials